Company / EPS (Diluted)
BioNexus Gene Lab Corp EPS (Diluted) History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.17
FY2024
5-year range
-$0.17 / -$0.17
FY2020-FY2024
Trend
-
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $0.00 to $-0.17 over the past 5 years.
Based on SEC 10-K filings.
-0.17 in FY2024.
Declined from $0.00 to $-0.17 over the past 5 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Company context
Key Data Points
- Altman Z-Score 5.27 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | -$0.17 | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | $0.00 | - |
| FY2019 | $0.00 | - |
As of FY2024 · SEC Form 10-K · Last checked Jun 21, 2026